Bahl & Gaynor Inc. Has $40.33 Million Stock Position in U.S. Physical Therapy, Inc. $USPH

Bahl & Gaynor Inc. increased its stake in shares of U.S. Physical Therapy, Inc. (NYSE:USPH) by 47.6% during the 3rd quarter, HoldingsChannel.com reports. The fund owned 474,688 shares of the company’s stock after acquiring an additional 153,054 shares during the period. Bahl & Gaynor Inc.’s holdings in U.S. Physical Therapy were worth $40,325,000 as of its most recent SEC filing.

Other hedge funds have also recently bought and sold shares of the company. CWM LLC increased its position in shares of U.S. Physical Therapy by 17.0% during the 3rd quarter. CWM LLC now owns 968 shares of the company’s stock worth $82,000 after purchasing an additional 141 shares during the last quarter. PNC Financial Services Group Inc. increased its holdings in U.S. Physical Therapy by 4.8% during the third quarter. PNC Financial Services Group Inc. now owns 3,091 shares of the company’s stock worth $263,000 after buying an additional 142 shares during the last quarter. Assetmark Inc. raised its position in U.S. Physical Therapy by 35.7% during the second quarter. Assetmark Inc. now owns 570 shares of the company’s stock worth $45,000 after acquiring an additional 150 shares in the last quarter. Amalgamated Bank lifted its stake in U.S. Physical Therapy by 3.8% in the third quarter. Amalgamated Bank now owns 4,461 shares of the company’s stock valued at $379,000 after acquiring an additional 162 shares during the last quarter. Finally, Osaic Holdings Inc. lifted its stake in U.S. Physical Therapy by 1.6% in the second quarter. Osaic Holdings Inc. now owns 10,447 shares of the company’s stock valued at $817,000 after acquiring an additional 166 shares during the last quarter.

U.S. Physical Therapy Stock Up 4.7%

U.S. Physical Therapy stock opened at $83.04 on Monday. The company’s 50-day moving average price is $83.60 and its two-hundred day moving average price is $82.45. The company has a quick ratio of 1.20, a current ratio of 1.01 and a debt-to-equity ratio of 0.32. The stock has a market cap of $1.26 billion, a P/E ratio of 58.48, a P/E/G ratio of 2.08 and a beta of 1.30. U.S. Physical Therapy, Inc. has a twelve month low of $62.77 and a twelve month high of $93.50.

U.S. Physical Therapy (NYSE:USPH) last posted its earnings results on Wednesday, February 25th. The company reported $0.67 EPS for the quarter, meeting the consensus estimate of $0.67. The company had revenue of $202.73 million for the quarter, compared to the consensus estimate of $200.10 million. U.S. Physical Therapy had a return on equity of 8.75% and a net margin of 5.07%.The firm’s revenue for the quarter was up 12.3% on a year-over-year basis. During the same quarter in the prior year, the business earned $0.51 earnings per share. As a group, analysts expect that U.S. Physical Therapy, Inc. will post 2.67 EPS for the current year.

U.S. Physical Therapy Increases Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Friday, April 10th. Shareholders of record on Friday, March 13th will be given a dividend of $0.46 per share. This represents a $1.84 annualized dividend and a yield of 2.2%. The ex-dividend date is Friday, March 13th. This is a positive change from U.S. Physical Therapy’s previous quarterly dividend of $0.45. U.S. Physical Therapy’s dividend payout ratio (DPR) is 126.76%.

Analyst Ratings Changes

Several research analysts have recently weighed in on USPH shares. JPMorgan Chase & Co. lowered their price objective on shares of U.S. Physical Therapy from $110.00 to $100.00 and set an “overweight” rating on the stock in a research note on Monday, November 24th. Citigroup reissued a “market outperform” rating on shares of U.S. Physical Therapy in a research report on Monday, December 15th. Barrington Research reiterated an “outperform” rating and set a $103.00 target price on shares of U.S. Physical Therapy in a research note on Friday, February 20th. Finally, Weiss Ratings reissued a “hold (c)” rating on shares of U.S. Physical Therapy in a report on Wednesday, January 21st. Four equities research analysts have rated the stock with a Buy rating and two have issued a Hold rating to the company. According to data from MarketBeat.com, U.S. Physical Therapy presently has a consensus rating of “Moderate Buy” and an average target price of $105.33.

About U.S. Physical Therapy

U.S. Physical Therapy, Inc (NYSE: USPH) is a leading owner and operator of outpatient physical therapy clinics across the United States. The company delivers rehabilitative care to patients recovering from orthopedic injuries, neurological disorders and chronic conditions. Its core services include one-on-one physical therapy sessions, aquatic therapy, occupational therapy, massage therapy and sports medicine programs designed to restore mobility and enhance quality of life.

In addition to traditional rehabilitation services, U.S.